Fluticasone Propionate Aerosol, Metered
NDC Package 66993-080-96
Package Information
Fluticasone Propionate aerosols is fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. This formulation utilizes a aerosol, metered delivery system. Marketed by Prasco Laboratories, this product is identified by NDC 66993-080 and is authorized under FDA application NDA021433.
Identification & Billing
- RxCUI: 895994 - fluticasone propionate 44 MCG/INHAL Metered Dose Inhaler, 120 Actuations
- RxCUI: 895994 - 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler
- RxCUI: 895994 - fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler, 120 ACTUAT
- RxCUI: 895999 - fluticasone propionate 110 MCG/INHAL Metered Dose Inhaler, 120 Actuations
- RxCUI: 895999 - 120 ACTUAT fluticasone propionate 0.11 MG/ACTUAT Metered Dose Inhaler
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66993 - Prasco Laboratories
- 66993-080 - Fluticasone Propionate
- 66993-080-96 - 1 INHALER in 1 CARTON / 120 AEROSOL, METERED in 1 INHALER
- 66993-080 - Fluticasone Propionate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66993-080-96 identifies a specific commercial package of 1 inhaler in 1 carton / 120 aerosol, metered in 1 inhaler of Fluticasone Propionate Hfa, a human prescription drug labeled by Prasco Laboratories. This aerosol, metered is formulated for respiratory (inhalation) use and contains fluticasone propionate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Prasco Laboratories on May 23, 2022. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. It can also help relieve allergy eye symptoms such as itchy, watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works in your nose to block the effects of substances that cause allergies (such as pollen, pet dander, dust mites, mold) and to reduce swelling.
How is this Prasco Laboratories product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66993008096. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.